During a world first therapy, Mater Researcher and Haematologist Professor Maher Gandhi 46-year-old patient Scott Griffiths has been successfully cured of a rare type of lymphoma.

Launched in early September, the taskforce has begun to help raise awareness for Australian living with blood cancers to get the help they need.

The Blood Cancer Taskforce, a collaboration of some of the country’s top blood cancer experts and leaders launched today.

February is Ovarian Cancer Awareness Month held to educate people however Mater is providing hope with research and treatment.

Mater Researcher A/Prof Kristen Radford has been awarded a 2020 Fulbright Future Scholarship allowing her to progress her cancer research with a four month sabbatical at the Tisch Cancer Institute.

Professor Brian Gabrielli and team seek out the to answer a question—what is broken in melanomas that allows the damage to accumulate rather than repair, leading to mutations?

Collaboration between clinical research institutes the Griffith Institute for Drug Discovery, Mater Research and Translational Research Institute has led to a breakthrough in cancer research.

Mater Researcher Dr Felicity Davis has been awarded one of two $50,000 Metcalf Prizes from the National Stem Cell Foundation of Australia.

Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.

Mater Research CEO and MRI-UQ Director Professor Maher Gandhi and his team report that immune-infiltration is a promising tool to improve outcomes for patients with follicular lymphoma.

More Australians living with follicular lymphoma could benefit from tailored treatment through development of a new clinical scoring model thanks to Mater Research.

Mater Research—University of Queensland (MRI—UQ) Acting Director Professor Maher Gandhi has been awarded $3.6 million to improve treatment for relapsed lymphoma patients.